Found 15 matching trials
A Phase II Study of Linperlisib (YY-20394) in Patients With Relapsed or Refractory Peripheral T/NK Cell Lymphoma
PHASE2This is a Phase II, single-arm study to evaluate the efficacy, safety, and ...
Location
MD Anderson Cancer Center
SHR1459 in Combination With YY-20394 in Recurrent and Refractory B-cell Non-Hodgkin's Lymphoma
PHASE2The study is evaluating the efficacy, and safety of SHR1459 combined with Y...
Location
Ruijin Hospital Affiliated to The Shanghai Jiao Tong University Medical School
Linperlisib Combined With Camrelizumab and Pegaspargase in Advanced or Relapsed/Refractory NK/T-cell Lymphoma
PHASE1The patients diagnosed with relapsed/refractory or advanced NK/T-cell Lymph...
Real World Study of Linperlisib for Lymphoma Treatment
N/AThis is a multicenter, non-interventional and observational real-world stud...
Location
Ruijin Hospital, Shanghai Jiao Tong University School of Medicine
A Phase Ib Study of YY-20394 in Participants With B-cell Hematologic Malignancies
PHASE1Protocol YY-20394-007 is a phase1 open-label, single-arm, multi-centre stud...
Location
Hematology Hospital of the Chinese Academy of Medical Sciences
A Phase I Study of YY-20394 in Patients With Advanced Solid Tumors
PHASE1Protocol YY-20394-003 is a phase I single arm, open label study. The primar...
Location
Shanghai East Hospital
A Phase 2 Clinical Study of YY-20394 in Patients With Relapsed/Refractory Follicular Lymphoma
PHASE2A Phase 2, single arm, open label clinical study to evaluate the efficacy, ...
Location
Multiple Locations
YY-20394 、GEMOX Treatment Diffuse Large B-cell Lymphoma Single Arm, Open, Multicentrized Phase 1b/2 Clinical Trial
PHASE1This study is a one-arm, open, multicenter phase 1b/2 clinical trial of YY-...
Location
Multiple Locations
A National Multicenter, Real-world Study of Linperlisib in the Treatment of Lymphoma
PHASE4This is a national multicenter, randomized controlled, open, dose-optimized...
Location
Multiple Locations
A Phase Ib Study of YY-20394 in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
PHASE1A single-arm, open, multicenter study to investigate the efficacy and safet...
Location
Hematology Hospital of Chinese Academy of Medical Sciences